ARDS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 14:52):
Our systems believe the stock currently is undervalued by 6.84% compare to its pairs and should correct upwards.

Stats
Today's Volume	158 414
Average Volume	92 419
Market Cap	2.67M
EPS	$-0.00220 ( Q3 \| 2023-11-06 )
Next earnings date	( $0 ) 2024-09-11
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.370 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00300 (4.67%)

AADI -2.74%

ABCL -6.08%

ABCM 0.04%

ABEO -0.94%

ABIO -0.78%

ABOS -1.45%

ABSI -2.27%

ABUS 0.97%

ABVX 2.57%

ACAD -1.29%

ACER -17.95%

ACET -4.96%

ACGN 1.29%

ACHL -1.60%

ACHV 1.70%

ACIU -0.25%

ACLX -2.88%

ACRV 1.03%

ACST -2.34%

ACXP -4.89%

ADAG -0.33%

ADAP 7.70%

ADGI 0.87%

ADIL -5.22%

ADMA 3.31%

ADPT -0.55%

ADTX 14.49%

ADVM 1.60%

ADXN -12.26%

AEON -0.95%

AEZS 3.07%

AFMD -0.73%

AGEN -0.36%

AGIO 0.60%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -2.51%

AKRO -1.28%

AKTX 15.23%

AKUS 0.00%

ALBO 0.00%

ALDX -1.81%

ALEC -2.64%

ALGS 5.43%

ALKS 1.20%

ALLK -12.02%

ALLO 0.00%

ALLR 6.44%

ALNA 3.16%

ALNY 0.13%

ALPN 0.02%

ALPX 0.00%

ALRN 1.08%

ALT 8.27%

ALVR 0.93%

ALXN 0.00%

ALXO -0.66%

ALZN 0.91%

AMRN -0.29%

AMTI -3.13%

ANAB -1.80%

ANEB -1.83%

ANGN 0.00%

ANIX 0.45%

ANL -6.05%

ANNX 3.06%

ANPC -3.15%

APGE -1.96%

APGN 8.48%

APGNW 30.65%

APLM 0.96%

APLS -5.40%

APLT -1.28%

APM -7.51%

APOP 0.38%

APRE -0.98%

APTO -1.51%

APTX 3.17%

APVO 9.15%

ARAV -13.39%

ARCT -2.83%

ARDS 19.76%

ARDX 2.16%

ARGX 0.97%

ARNA 0.00%

ARPO -0.90%

ARQT 2.80%

ARTL -3.57%

ARTLW 0.00%

ARVN -2.40%

ARWR 0.23%

ASLN 0.00%

ASMB -3.50%

ASND -1.76%

ATAI 1.50%

ATHA -5.28%

ATHE 0.00%

ATHX -33.50%

ATNF -7.98%

ATOS 0.84%

ATRA -1.65%

ATXI -2.86%

ATXS 1.65%

AUPH -3.85%

AURA -2.51%

AUTL -0.29%

AVBP -2.16%

AVEO 0.00%

AVIR 1.81%

AVRO -1.41%

AVTE 2.41%

AVTX 1.12%

AVXL -2.61%

AXLA 0.00%

AXSM 0.66%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO -0.51%

BCAB -1.46%

BCDA 0.67%

BCDAW 0.00%

BCEL 0.00%

BCLI 5.47%

BCRX 7.93%

BCTX -4.39%

BCTXW 17.17%

BCYC 0.25%

BDRX -0.23%

BDTX 0.86%

BEAM -1.62%

BFRA -2.91%

BGNE 1.56%

BIOR -4.56%

BIVI 4.00%

BLCM -6.68%

BLI -5.88%

BLPH -1.93%

BLRX -1.06%

BLTE 0.31%

BLU 0.03%

BLUE -0.90%

BMEA -1.78%

BMRN -0.24%

BNOX -10.04%

BNTC 3.92%

BNTX -1.90%

BOLD 8.27%

BOLT -2.41%

BPMC 1.30%

BPTH -3.00%

BPTS -13.47%

BRNS 2.14%

BRTX -2.46%

BTAI -8.59%

BTTX -15.97%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.92%

CABA 4.41%

CADL 1.61%

CALA 0.00%

CALC 7.32%

CALT -0.62%

CAPR 1.47%

CARA 1.94%

CARM 9.87%

CASI -1.82%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.89%

CCCC 4.98%

CCXI 0.00%

CDAK 0.00%

CDIO -1.82%

CDIOW 6.00%

CDMO -0.28%

CDMOP 0.04%

CDT -6.12%

CDTTW 72.08%

CDTX 0.84%

CDXC -1.47%

CDXS -3.55%

CELC 1.59%

CELU 1.92%

CELUW 1.32%

CERC -1.68%

CERE 1.13%

CERO -8.16%

CEROW 43.57%

CFRX -27.95%

CGEM -4.07%

CGEN 4.17%

CGON 0.48%

CGTX 0.60%

CHMA -6.00%

CHRS -6.94%

CINC 0.00%

CING 7.50%

CINGW 4.85%

CKPT -4.65%

CLBS -16.75%

CLDX 5.35%

CLGN 1.00%

CLLS 3.48%

CLNN 0.22%

CLNNW 44.05%

CLRB 2.00%

CLSD -4.62%

CLSN -0.68%

CLVS 0.00%

CMMB 5.00%

CMND -1.19%

CMPI 0.00%

CMPX -5.45%

CMRA 0.00%

CMRAW 33.33%

CMRX -0.80%

CNCE 0.00%

CNSP -10.13%

CNST 0.00%

CNTA -2.55%

CNTB -5.26%

CNTX -9.73%

COCP 3.00%

COEPW 0.00%

COGT 6.05%

CORT 0.55%

COYA 0.66%

CPRX 1.81%

CRBP 9.17%

CRBU -3.05%

CRDF -7.66%

CRGX -2.56%

CRIS -7.54%

CRNX 2.86%

CRSP -0.11%

CRTX 2.63%

CRVO -5.84%

CRVS 1.65%

CSBR -4.26%

CTCX 23.31%

CTIC 0.06%

CTMX 9.02%

CTNM 19.25%

CTXR -6.92%

CUE -17.74%

CVAC -2.06%

CVKD -1.15%

CWBR 0.00%

CYAD -12.96%

CYCC 0.00%

CYCCP -11.68%

CYCN 0.88%

CYT -2.27%

CYTK 0.96%

CYTO 9.91%

DARE -6.03%

DAWN -1.45%

DBTX -0.81%

DBVT 2.20%

DFFN 10.28%

DICE 0.06%

DMAC 0.00%

DNLI -5.21%

DNTH 11.55%

DOMH 4.81%

DRMA -5.37%

DRMAW 7.69%

DRNA 0.00%

DRTS 0.79%

DRTSW 19.05%

DRUG -2.77%

DSGN -2.99%

DTIL 1.64%

DYAI 3.38%

EARS -1.77%

EDIT -1.28%

EDSA 2.09%

EFTR -8.00%

EFTRW -41.67%

EIGR -9.21%

ELAB 0.07%

ELDN -4.92%

ELEV 5.93%

ELOX 1.45%

ELTX -8.03%

ELVN -2.87%

ELYM -0.84%

ENGN -4.03%

ENGNW -2.88%

ENLV -2.82%

ENOB 1.79%

ENSC -1.23%

ENTA 0.77%

ENTO -11.11%

ENTX -4.35%

ENVB -5.90%

EPIX -2.66%

EPRX 2.38%

EPZM 0.00%

EQ -2.21%

EQRX -2.09%

EQRXW 0.00%

ERAS 3.39%

ERNA 4.14%

ERYP 1.30%

ESLA 4.76%

ESLAW 0.00%

ETNB -3.12%

ETON 3.34%

ETTX 0.00%

EVAX 0.70%

EVGN -0.91%

EVLO 39 899.32%

EWTX 7.61%

EXAI 0.98%

EXEL -0.98%

EYEG -0.51%

EYEN 14.27%

EYPT -4.48%

FATE -0.61%

FBIO -1.17%

FBIOP 0.70%

FBLG -19.84%

FBRX 1.68%

FDMT 1.67%

FENC 2.62%

FGEN -13.69%

FHTX 1.57%

FIXX 0.77%

FMTX 0.00%

FNCH -10.95%

FOLD -1.21%

FREQ 4.76%

FRLN 0.15%

FRTX -4.21%

FSTX 0.00%

FTRE 2.23%

FULC 1.77%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 3.98%

GANX -12.50%

GBIO -8.87%

GBT 0.01%

GDTC -0.99%

GERN 2.36%

GHRS 0.77%

GLMD -1.01%

GLPG 0.93%

GLSI -2.84%

GLTO -1.73%

GLUE 5.35%

GLYC 5.15%

GMAB -1.11%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT 10.80%

GNLX -5.64%

GNPX 2.39%

GNTA -0.87%

GOSS 5.18%

GOVX 2.98%

GOVXW -10.37%

GPCR 1.86%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -6.13%

GRTX -8.63%

GTHX 8.33%

GUTS 4.45%

GXGXW 41.67%

GYRE 0.92%

HALO -0.65%

HARP 0.09%

HCWB 0.46%

HEPA -0.93%

HGEN -84.62%

HILS 5.66%

HLVX -0.28%

HOOK 6.17%

HOTH -1.12%

HOWL -3.69%

HRMY 0.83%

HRTX -0.86%

HSTO 0.00%

HUMA 11.88%

HUMAW 22.30%

IBRX -0.79%

ICCC -8.04%

ICPT 0.21%

ICU 23.06%

ICUCW 13.26%

ICVX -0.91%

IDRA -23.04%

IDYA 2.31%

IFRX -1.72%

IGMS -1.16%

IKNA 0.00%

IKT -5.34%

IMAB -2.99%

IMCR 7.49%

IMGN 0.02%

IMGO 0.00%

IMMP 0.00%

IMMX 7.07%

IMNM 0.83%

IMNN 8.62%

IMPL -27.27%

IMRA 15.96%

IMRN -9.26%

IMRX -8.59%

IMTX 3.27%

IMTXW 27.41%

IMUX 0.90%

IMV 0.00%

IMVT 4.20%

INAB -3.95%

INBX -3.03%

INCY 0.41%

INDP 4.25%

INFI -52.38%

INKT -3.51%

INM -5.24%

INMB -4.54%

INO 6.56%

INSM -0.99%

INTS 0.41%

INVA 0.61%

INZY -1.12%

IOBT -4.27%

IONS -1.15%

IOVA 0.50%

IPA -3.71%

IPHA 7.22%

IPSC -5.49%

IRON 3.11%

ISEE 0.38%

ITOS 1.15%

ITRM -5.60%

IVA -1.19%

IVVD 9.09%

JAGX -2.79%

JANX -0.41%

JAZZ -0.24%

JNCE 0.00%

JSPR 1.94%

JSPRW 5.15%

JUNS 0.00%

JUNSW 0.00%

KA 4.20%

KALV 0.93%

KDNY 0.22%

KMPH -0.34%

KNSA -3.59%

KNTE -0.38%

KOD 0.85%

KPRX 3.57%

KPTI -6.01%

KRBP -1.83%

KRON -9.68%

KROS -4.22%

KRRO -0.06%

KRTX 0.03%

KRYS -0.75%

KTRA 10.14%

KTTA 0.38%

KTTAW 1.83%

KURA 2.96%

KYMR 3.69%

KYTX 4.13%

KZIA -4.91%

KZR -2.73%

LABP 0.57%

LBPH 14.39%

LBPS 0.00%

LBPSW 14.81%

LEGN 3.91%

LENZ 2.31%

LEXX -0.72%

LEXXW 23.90%

LGND 0.70%

LGNDV 0.00%

LGVN -2.48%

LIAN -8.28%

LIFE 2.70%

LIPO -3.41%

LIXT -0.38%

LIXTW -3.71%

LJPC -0.32%

LMNL 0.12%

LOGC -3.15%

LPCN -6.31%

LPTX -4.59%

LQDA 0.33%

LRMR 13.66%

LSTA 2.31%

LTRN -3.21%

LUMO -2.46%

LVTX 3.89%

LXEO -2.68%

LXRX -0.30%

LYEL 8.97%

LYRA 7.30%

MACK 0.10%

MBIO 2.41%

MBRX -1.15%

MCRB -0.25%

MDGL -0.30%

MDNA -13.16%

MDWD -0.84%

MDXG -3.32%

MEIP -2.06%

MESO -0.44%

MGNX 1.18%

MGTA -7.74%

MGTX -2.61%

MGX 8.33%

MIRM -0.09%

MIRO 0.59%

MIST 0.75%

MITO 0.00%

MLEC -0.88%

MLECW -31.50%

MLND -5.36%

MLTX -4.94%

MLYS 4.02%

MNKD -2.49%

MNMD -1.94%

MNOV 0.00%

MNPR -0.88%

MOLN 2.80%

MOR -0.22%

MORF -4.46%

MREO 0.83%

MRKR -0.74%

MRNA -2.36%

MRNS 9.40%

MRSN -1.99%

MRTX -0.17%

MRUS -7.98%

MRVI -3.07%

MTCR -1.29%

MTEM 2.61%

MTP -18.50%

MURA -0.96%

MYMD 0.00%

NAMS 7.13%

NAMSW -4.76%

NAUT -2.99%

NBRV 0.71%

NBSE -1.56%

NBTX 7.00%

NCNA 7.36%

NERV -0.86%

NEXI -6.90%

NGM -1.28%

NGNE 11.62%

NKGN 0.00%

NKGNW -12.00%

NKTR -1.61%

NKTX -1.02%

NLSP -9.50%

NLSPW 26.58%

NMRA 1.12%

NMTR -42.97%

NOVN -24.84%

NRBO -6.20%

NRIX 0.19%

NRSN -3.57%

NRSNW -2.91%

NRXP 5.74%

NRXPW 41.43%

NRXS 1.44%

NTBL -6.12%

NTEC -12.45%

NTHI 0.00%

NTLA 0.40%

NTRBW 74.65%

NUVL -0.46%

NVAX 0.55%

NVCT -2.37%

NVIV -34.28%

NXTC -5.66%

NYMX -0.05%

OABI -0.27%

OABIW -9.28%

OBIO -12.64%

OBSV 0.00%

OCEA -3.28%

OCGN 4.84%

OCS -0.50%

OCUL -2.63%

OCUP 3.92%

ODT -4.27%

OKYO 1.64%

OLMA 2.96%

OMER -2.71%

OMGA 8.70%

ONCO -6.10%

ONCR -3.08%

ONCS 31.87%

ONCT -7.70%

ONCY 0.53%

ONTX -0.47%

ONVO -0.34%

OPNT 0.00%

OPT -0.99%

ORGS 8.13%

ORIC 8.06%

ORMP -0.39%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK 0.41%

OVID 12.09%

OYST 0.00%

PALI -5.29%

PASG 11.43%

PBLA -10.00%

PBM 6.33%

PBYI 0.61%

PCSA -7.11%

PCVX 1.89%

PDSB 3.41%

PEPG 12.22%

PGEN -1.90%

PHAR -4.62%

PHAS 0.00%

PHAT 4.95%

PHIO -3.88%

PHIOW 36.47%

PHVS -0.59%

PHXM -5.20%

PIRS -1.82%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 1.02%

PLUR -0.43%

PMN 6.67%

PMVP -2.47%

PNT 0.16%

PPBT -13.47%

PRAX -0.41%

PRDS 0.93%

PRLD -1.05%

PROG -3.47%

PROK 1.63%

PRQR -0.60%

PRTA -0.78%

PRTC 3.68%

PRTG -7.63%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 2.04%

PSTX 3.08%

PTCT 1.93%

PTE -0.82%

PTGX 1.59%

PTIXW -48.41%

PULM 1.55%

PXMD -1.27%

PYPD -0.24%

PYXS -3.32%

QLGN -3.77%

QNCX -3.33%

QNRX 1.75%

QSI -11.01%

QSIAW 4.08%

QTTB 5.74%

QURE -0.78%

RAIN -1.63%

RANI 0.53%

RAPT -5.57%

RARE 0.05%

RCKT -4.04%

REGN 0.57%

RENB -10.86%

REPL 4.00%

RETA 0.02%

REUN -0.89%

REVB -1.58%

REVBU 3.46%

REVBW 0.00%

RGLS 6.44%

RGNX -5.38%

RIGL 2.31%

RLAY -1.84%

RLMD 2.33%

RLYB 1.49%

RNA 1.05%

RNAC -10.14%

RNAZ -4.54%

RNXT 1.77%

ROIV 2.46%

ROIVW 4.56%

RPHM 2.65%

RPRX -0.68%

RPTX 0.91%

RUBY 2.70%

RVLP -32.05%

RVMD 0.00%

RVMDW -1.40%

RVNC 0.00%

RVPH -7.03%

RVPHW 4.88%

RXDX 0.09%

RXRX -0.53%

RYTM 3.92%

RYZB 0.02%

RZLT 0.23%

SABS -1.94%

SABSW 54.57%

SAGE 1.57%

SANA 0.18%

SAVA -1.70%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 3.16%

SCPH -0.69%

SCPS 0.00%

SEEL 3.69%

SEER 0.60%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -7.90%

SGMT -7.60%

SGTX -2.56%

SIOX 22.63%

SLDB 10.58%

SLGL -4.21%

SLN -1.37%

SLNO 3.65%

SLRX -7.92%

SLS -0.84%

SMMT 4.36%

SNDX 4.87%

SNGX -4.26%

SNPX 1.97%

SONN -0.80%

SPPI -0.49%

SPRB 2.55%

SPRC -5.98%

SPRO -1.54%

SRNE -20.00%

SRPT -0.79%

SRRA 0.00%

SRRK -2.40%

SRZN -2.28%

STAB 0.00%

STOK 2.66%

STRO 4.10%

STSA 0.00%

STTK 3.37%

SURF -0.93%

SVRA 15.14%

SWTX 2.28%

SYBX -0.67%

SYRS -4.46%

TALS -0.73%

TARA 0.48%

TARS 3.90%

TBPH 0.47%

TCBP 1.76%

TCDA 0.00%

TCON -30.63%

TCRR 0.00%

TCRT -6.87%

TCRX 1.37%

TECH -0.06%

TENX -1.32%

TERN 0.59%

TFFP 7.23%

TGTX 2.02%

THRX 0.12%

TIL 0.10%

TLC 0.00%

TLSA -3.63%

TNGX 4.90%

TNXP 4.96%

TNYA 8.71%

TPST -2.28%

TRDA 0.49%

TRVI -3.02%

TRVN -3.81%

TSHA 0.89%

TSVT 5.19%

TTNP -0.18%

TVTX 0.73%

TYRA 8.07%

UBX -1.48%

UNCY 7.76%

URGN -1.79%

UTHR 0.14%

VACC 11.36%

VALN -3.27%

VAXX 20.24%

VBIV 4.85%

VBLT -8.77%

VCEL -1.85%

VCNX -0.15%

VCYT -1.57%

VERA 0.30%

VERU 4.45%

VERV 2.05%

VIGL 9.25%

VINC -6.26%

VIR 2.25%

VIRI 3.26%

VIRX -6.20%

VKTX 4.36%

VLON -13.04%

VNDA -1.24%

VOR -1.07%

VRCA 9.05%

VRDN 1.54%

VRNA 7.26%

VRPX -1.59%

VRTX 0.54%

VSTM 9.06%

VTGN 2.59%

VTVT -0.42%

VTYX -2.16%

VXRT 3.19%

VYGR -0.63%

VYNE -2.54%

VYNT 7.78%

WINT 0.00%

WVE 4.91%

XBIO -0.48%

XBIT 7.98%

XCUR -3.93%

XENE -3.33%

XERS -3.56%

XFOR 1.62%

XLO -2.49%

XLRN 0.00%

XNCR 0.48%

XOMA 5.11%

XOMAO 0.20%

XOMAP 1.98%

XRTX -1.06%

YMAB -2.07%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -0.23%

ZNTL 2.45%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-27	Windham-bannister Susan Richards	Buy	200 000	Stock options
2024-06-27	Hamilton John F	Buy	200 000	Stock options
2024-06-27	Jafri Hasan	Buy	250 000	Stock options
2024-06-24	Patzer Eric	Buy	714 286	Common stock purchase
2024-06-24	Truong Vu	Buy	714 286	Common stock purchase

INSIDER POWER
97.87
Last 98 transactions
Buy: 3 822 707 \| Sell: 1 190 370

Correlation (AI algo v.1.1b): Undervalued: 6.84% $0.0686 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Aridis Pharmaceuticals Correlation

10 Most Positive Correlations
OZEM	1
VIAV	0.827
DHCNI	0.825
CTRN	0.822
KOPN	0.821
NCNA	0.816
ATRC	0.812
VAXX	0.81
AGMH	0.809
TFFP	0.808

10 Most Negative Correlations
LE	-0.828
CHCI	-0.826
IZEA	-0.804
CSTE	-0.803

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aridis Pharmaceuticals Financials

Annual	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-1.640

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-1.640

FY	2021
Revenue:	$1.54M
Gross Profit:	$1.54M (100.00 %)
EPS:	$-0.0270

FY	2020
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-2.44

Financial Reports:

No articles found.

Aridis Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Aridis Pharmaceuticals

Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin. The company is also developing AR-320 is a fully human IgG1 monoclonal antibody targeting S. aureus alpha toxin to treat infections caused by methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus; AR-105, a fully human IgG1 mAb, which is in Phase II trials to target gram-negative bacteria P. aeruginosa; AR-101, a human IgM mAb, which is in Phase IIa clinical trials for the treatment of hospital-acquired pneumonia (HAP)and ventilator-associated pneumonia (VAP) caused by P. aeruginosa serotype O11; AR-401 that is in preclinical stage to treat infections caused by Acinetobacter baumannii; AR-201, a fully human IgG1 mAb preclinical program for respiratory syncytial virus; and AR-501, an anti-infective therapy, which is in Phase I/IIa clinical trial to manage chronic lung infections in cystic fibrosis patients. In addition, it is developing AR-712 and AR-701, a cocktail of two fully human immunoglobulin 1, or IgG1, mAbs, which is in Phase I/II clinical for the treatment of mild to moderate non-hospitalized COVID-19 patients. Aridis Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Los Gatos, California.